Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUMELTT, PBSC, and IL-2/GM-CSF in Stage IIIB/IV Breast Cancer
NCT00003199Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 1997
- Primary completion
- Dec 2009
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin, sargramostim, busulfan, melphalan, thiotepa in breast cancer, sponsored by Fred Hutchinson Cancer Center. Started Nov 1997; status: completed.
02
Drugs
aldesleukinsargramostimbusulfanmelphalanthiotepa
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003199.